United Therapeutics Corp (UTHR)

178.49 -3.92  -2.15% NASDAQ Jun 18, 20:00 USD
View Full Chart
Price Chart
View All UTHR News


View All Events


Date Type Description
07/29/2021 Earnings Results Q2 2021 Earnings Results
07/29/2021 09:00 EST Earnings Calls Q2 2021 Earnings Call
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 09:00 EST Earnings Calls Q1 2021 Earnings Call
02/24/2021 Earnings Results Q4 2020 Earnings Results
02/24/2021 09:00 EST Earnings Calls Q4 2020 Earnings Call
10/28/2020 Earnings Results Q3 2020 Earnings Results
10/28/2020 09:00 EST Earnings Calls Q3 2020 Earnings Call
07/29/2020 09:00 EST Earnings Calls Q2 2020 Earnings Call
07/29/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for pulmonary arterial hypertension largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Nearly all of its sales are generated within the United States. United also markets a pediatric oncology drug, but its focus largely remains in pulmonary hypertension.
  • URL: https://www.unither.com
  • Investor Relations URL: https://ir.unither.com/
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: Jul. 29, 2021
  • Last Earnings Release: May. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PJP Invesco Dynamic Pharmaceuticals ETF 3.11%
FTHAX Fuller & Thaler Behavioral Sm-Cp Eq A 2.37%
FDMLX Fidelity® Series Intrinsic Opps 2.09%
XMMO Invesco S&P MidCap Momentum ETF 1.90%
RSQCX Royce Special Equity Consult 1.90%
FXH First Trust Health Care AlphaDEX® ETF 1.89%
DLRHX Delaware Healthcare R 1.40%
HSPCX Emerald Growth C 1.28%
SMMV iShares MSCI USA Sm-Cp Min Vol Fctr ETF 0.99%
XBI SPDR® S&P Biotech ETF 0.79%
FID6027 Fidelity Global Intrinsic Value Cl P4T5 0.78%
XT iShares Exponential Technologies ETF 0.60%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.